TSx-Cover

Acne Vulgaris

Thiboutot D (2011) Dermatologists do not yet fully understand the clinical significance of antibiotic use and bacterial resistance in patients with acne, Arch Derm, 147:921-922.

Thiboutot et al (2009) New insights into the management of acne: an update from the Global Alliance to improve outcomes in acne group; J Am Acad Derm, 60(5 Suppl): S1-50.

Del Rosso JQ, Kim G (2009) Optimizing use of oral antibiotics in acne vulgaris; Dermatol Clin, 27(1):33-42.

Bhate K, Williams HC (2013) Epidemiology of acne vulgaris, BJD, 168:474-485.

Strauss et al (2007) Guidelines of care for acne vulgaris management; J Am Acad Derm, 56;4: 651-663.

Turowski CB, James WD (2007) The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris; Adv Dermatol, 23: 155-63.

James WD (2005) Clinical practice. Acne; N Engl J Med, 352(14): 1463-1472.